HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.

AbstractOBJECTIVE:
The objective was to test a bispecific ligand-directed toxin (BLT), with reduced immunogenicity for enhanced efficacy in targeting orthotopic pancreatic cancer in vivo.
METHOD:
A new BLT was created in which both human epidermal growth factor (EGF) and interleukin 4 cytokines were cloned onto the same single chain molecule with deimmunized pseudomonas exotoxin (dEGF4KDEL). Key amino acids dictating B-cell generation of neutralizing antitoxin antibodies were mutated. Bioassays were used to determine whether mutation reduced potency, and enzyme-linked immunosorbent assay studies were performed to determine whether antitoxin antibodies were reduced. A genetically altered luciferase MIA PaCa-2 xenograft model was used to image in real time and determine effects on systemic malignant human cancer. Bispecific ligand-directed toxins targeting B cells were used as specificity controls.
RESULTS:
Deimmunized EGF4KDEL was significantly effective after systemic injection against established orthotopic MIA PaCa-2 pancreatic cancer and selectively prevented metastasis. Mutagenesis significantly reduced antitoxin levels in vivo with no apparent activity loss in vitro. The drug was effective against 3 human pancreatic cancer lines in vitro, MIA PaCa-2, SW1990, and S2VP10.
CONCLUSIONS:
Despite the metastatic nature of the MIA PaCa-2 orthotopic tumor xenografted in nude mice, high percentages of tumors responded to extended dEGFKDEL treatment resulting in significant anticancer effects and disease-free survivors.
AuthorsSeunguk Oh, Deborah A Todhunter, Angela Panoskaltsis-Mortari, Donald J Buchsbaum, Shoko Toma, Daniel A Vallera
JournalPancreas (Pancreas) Vol. 41 Issue 5 Pg. 789-96 (Jul 2012) ISSN: 1536-4828 [Electronic] United States
PMID22258068 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bispecific
  • Antineoplastic Agents
  • Exotoxins
  • Immunotoxins
  • Ligands
  • Interleukin-4
  • Epidermal Growth Factor
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies, Bispecific (immunology, pharmacology)
  • Antineoplastic Agents (immunology, pharmacology)
  • Cell Line, Tumor
  • Epidermal Growth Factor (genetics, immunology)
  • Exotoxins (genetics, immunology)
  • Humans
  • Immunotoxins (genetics, immunology, pharmacology)
  • Interleukin-4 (genetics, immunology)
  • Ligands
  • Male
  • Mice
  • Mice, Nude
  • Mutation
  • Pancreatic Neoplasms (drug therapy, immunology, pathology)
  • Pseudomonas (genetics, immunology)
  • Time Factors
  • Tumor Burden (drug effects, immunology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: